96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2019-000852-32-NL
(EUCTR)
30/01/202008/10/2019A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Disease that failed conventional treatment: The LDN Crohn study.A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Disease that failed conventional treatment: The LDN Crohn study. - The LDN Crohn study Inflammatory Bowel Disease, Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Product Name: Naltrexone hydrochlorideErasmusMCNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
122Phase 2Netherlands
2NCT01810185
(ClinicalTrials.gov)
March 201311/3/2013Low Dose Naltrexone in Symptomatic Inflammatory Bowel DiseaseLow Dose Naltrexone in Symptomatic Inflammatory Bowel DiseaseInflammatory Bowel Disease;Crohn's Disease;Ulcerative ColitisDrug: Low dose naltrexone;Drug: PlaceboSanta Barbara Cottage HospitalNULLWithdrawn18 YearsN/ABoth0Phase 2United States
3NCT00715117
(ClinicalTrials.gov)
July 200814/7/2008The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's DiseaseThe Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's DiseaseCrohn's DiseaseDrug: Naltrexone;Other: Placebo, sugar pillMilton S. Hershey Medical CenterNULLCompleted6 Years17 YearsAll14Phase 2United States
4NCT00663117
(ClinicalTrials.gov)
September 200618/4/2008The Effects of Naltrexone on Active Crohn's DiseaseThe Effects of Naltrexone in Active Crohn's DiseaseInflammation;Crohn's DiseaseDrug: Naltrexone-HCl;Drug: PlaceboMilton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);The Broad FoundationCompleted18 Years75 YearsAll40Phase 2United States